Christopher W. Gerry
General Counsel
Faeth Therapeutics, Inc. (FTH)Board Member
Faeth Therapeutics, Inc. (FTH)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Christopher W. Gerry
Christopher W. Gerry is recorded as General Counsel and Board Member at Faeth Therapeutics, Inc. (FTH). Faeth Therapeutics, Inc. reported in an 8-K filed June 15, 2026 that Christopher W. Gerry resigned as Director, effective June 12, 2026. Faeth Therapeutics, Inc. reported in an 8-K filed February 13, 2026 that Christopher W. Gerry was appointed director, effective February 13, 2026. The proxy statement of Faeth Therapeutics, Inc. reports total compensation of $434,600 for Christopher W. Gerry in fiscal 2025, including a base salary of $398,181.
“effective as of June 12, 2026, Christopher W. Gerry, Thomas Ricks and Kristian Humer resigned from the Board.”
“On February 13, 2026, the board of directors (the "Board") of Sensei Biotherapeutics, Inc. (the "Company") voted to increase the size of the Board from three members to five members and to appoint Christopher W. Gerry and Phillip B. Donenberg as new directors to fill the resulting vacancy, effective immediately, for a term until each of their respective successor is duly elected and qualified, or until each of their earlier death, resignation or removal.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2026-02-13–present
-
Current
Start not stated–present
-
2026-02-13–2026-06-12
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Faeth Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Anand Parikh CEO, Chairman, COO, Board Member
- John Celebi CEO, Board Member
- William Ringo Chairman, Board Member
- Brian Stephenson CFO
- Josiah Craver CFO, Chief Accounting Officer
- Bob Holmen Board Member
- Karen Vousden, Ph.D. Board Member
- Kristian Humer Board Member
- Phillip B. Donenberg Board Member
- Saira Ramasastry Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Faeth Therapeutics, Inc. (FTH) | President and General Counsel | $398,181 | $434,600 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.